Maxvita Pharma Private Limited
About Maxvita Pharma Private Limited
Data last updated:
Maxvita Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2013PTC245064.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It is led by directors Dipti Tejas Thakur and Tejas Vinay Thakur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.85 Lakh, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Lakh (net margin 4.9%) and EBITDA of ₹23.27 Lakh (EBITDA margin 97.6%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹2.77 Cr and satisfied charges of ₹69.75 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Maxvita Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 1/17 Vitta Sanchay Housing Society Near Rcf Factory Rcf – Mahul Road Chembu, R, Mumbai, Maharashtra, India – 400074
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxvita Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Maxvita Pharma are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and rental and leasing of motor vehicles, machinery, equipment, capital goods, etc. activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N1 | Rental and leasing of motor vehicles, machinery, equipment, capital goods, etc. activities |
To see the full business activity and turnover split of Maxvita Pharma Private Limited, buy the company report.
Financials of Maxvita Pharma Private Limited
FY 2025 filings availableMaxvita Pharma Private Limited reported revenue of ₹23.85 Lakh (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 8% fall in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.6% | ||||
| Net Profit Margin | 4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxvita Pharma Private Limited, buy the company report.
Board of directors of Maxvita Pharma Private Limited
Maxvita Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipti Tejas Thakur | Director | 11 Dec 2015 | 10 Years 10 Months | Current |
| Tejas Vinay Thakur | Director | 01 Jul 2013 | 13 Years 3 Months | Current |
Auditor
Maxvita Pharma Private Limited is audited by G S KANETKAR & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G S KANETKAR & COMPANY | FY 2023 | 143598W |
Shareholding
The shareholding of Maxvita Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxvita Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Nov 2019 | 100302395 | Others | ₹2.77 Cr | Open | |
| 21 Aug 2015 | 10588771 | Oriental Bank of Commerce | ₹65.75 Lakh | Satisfied | |
| 21 Aug 2015 | 10588773 | Oriental Bank of Commerce | ₹4 Lakh | Satisfied |
To see the full charge records of Maxvita Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Maxvita Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Maxvita Pharma Private Limited was last rated by Crisil on 15 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Oct 2020 |
To see the full credit ratings and regulatory alerts of Maxvita Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxvita Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Maxvita Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Maxvita Pharma Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Vinay Laxman Thakur ceased to be Director on 22 Feb 2025.
Frequently asked questions
Maxvita Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 July 2013 (13+ years old) and is registered under CIN U24299MH2013PTC245064.
Maxvita Pharma has 2 current directors:
- Dipti Tejas Thakur - Director
- Tejas Vinay Thakur - Director
The latest financial statements of Maxvita Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Maxvita Pharma is U24299MH2013PTC245064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxvita Pharma was incorporated on 01 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Vinay Laxman Thakur ceased to be Director on 22 Feb 2025. Dipti Tejas Thakur was appointed as Director on 11 Dec 2015. Sanjay Appasaheb Rote ceased to be Director on 08 Nov 2014. Maxvita Pharma has 4 board changes on record in total.
The registered office of Maxvita Pharma is at A – 117 Vitta Sanchay Housing Society Near Rcf Factory Rcf – Mahul Road Chembu, R, Mumbai, Maharashtra, India – 400074.
Maxvita Pharma operates in the pharma industry, in the drug formulation and development segment.
Maxvita Pharma has open charges of ₹2.77 Cr and satisfied charges of ₹69.75 Lakh as per latest MCA filings.
The compliance status of Maxvita Pharma is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.